UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Nature communications, 2021-08, Vol.12 (1), p.5112-5112, Article 5112

2021

Volltextzugriff (PDF)

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Nature communications, 2021-09, Vol.12 (1), p.5588-5588, Article 5588

2021

Volltextzugriff (PDF)

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

Breast cancer research : BCR, 2021-02, Vol.23 (1), p.26-18, Article 26

2021

Volltextzugriff (PDF)

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

BMC cancer, 2011-09, Vol.11 (1), p.418-418, Article 418

2011

Volltextzugriff (PDF)

MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer

Genes, 2021-05, Vol.12 (5), p.742

2021

Volltextzugriff (PDF)

Growth Hormone Is Secreted by Normal Breast Epithelium upon Progesterone Stimulation and Increases Proliferation of Stem/Progenitor Cells

Stem cell reports, 2014-06, Vol.2 (6), p.780-793

2014

Volltextzugriff (PDF)

Models of breast morphogenesis based on localization of stem cells in the developing mammary lobule

Stem cell reports, 2015-04, Vol.4 (4), p.699-711

2015

Volltextzugriff (PDF)

Identification of proteins involved in neural progenitor cell targeting of gliomas

BMC cancer, 2009-06, Vol.9 (1), p.206-206, Article 206

2009

Volltextzugriff (PDF)

A Novel Model of Dormancy for Bone Metastatic Breast Cancer Cells

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (23), p.6886-6899

2013

Volltextzugriff (PDF)

Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistance

Molecular oncology, 2024-08

2024

Volltextzugriff (PDF)

Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer

Molecular cell, 2021-04, Vol.81 (7), p.1453-1468.e12

2021

Volltextzugriff (PDF)

Abstract 5907: Fulvestrant resistance in estrogen receptor positive breast cancer models is driven by heterogeneous ER independent transcriptional programs

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5907-5907

2018

Volltextzugriff (PDF)

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

Breast cancer research : BCR, 2008-01, Vol.10 (3), p.R53-R53, Article R53

2008

Volltextzugriff (PDF)

Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium

Breast cancer research : BCR, 2014-05, Vol.16 (3), p.R52-R52, Article R52

2014

Volltextzugriff (PDF)

Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer

Breast cancer research and treatment, 2010-07, Vol.122 (2), p.315-324

2010

Volltextzugriff (PDF)

Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent

Journal of clinical pathology, 2015-12, Vol.68 (12), p.1012-1019

2015

Volltextzugriff (PDF)

Abstract LB-189: A role of Notch2 in quiescence of mammary stem/progenitor cells

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.LB-189-LB-189

2012

Volltextzugriff (PDF)

Neural progenitor cell lines inhibit rat tumor growth in vivo

Cancer research (Chicago, Ill.), 2004-08, Vol.64 (15), p.5347-5354

2004

Volltextzugriff (PDF)

Reduction of the putative CD44+CD24− breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047

Anti-cancer drugs, 2010-11, Vol.21 (10), p.897-906

2010

Volltextzugriff (PDF)

Abstract LB-307: Modeling the breast cancer metastatic niche

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.LB-307-LB-307

2012

Volltextzugriff (PDF)

Abstract LB-190: Growth hormone signaling in mammary stem and progenitor cells

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.LB-190-LB-190

2012

Volltextzugriff (PDF)

Chemokine-directed migration of tumor-inhibitory neural progenitor cells towards an intracranially growing glioma

Experimental cell research, 2006-05, Vol.312 (8), p.1265-1276

2006

Volltextzugriff (PDF)

Combretastatin A‐1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma

International journal of gynecological cancer, 2006-07, Vol.16 (4), p.1557-1564

2006

Volltextzugriff (PDF)

Identification and characterization of a human smad3 splicing variant lacking part of the linker region

Gene, 2004-03, Vol.327 (2), p.141-152

2004

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(6)
Breast Cancer Research : Bcr
(3)
Bmc Cancer
(2)
Breast Cancer Research
(2)
Nature Communications
(2)
Stem Cell Reports
(2)
Anti-Cancer Drugs
(1)
Breast Cancer Research And Treatment
(1)
Experimental Cell Research
(1)
Gene
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer

Growth Hormone Is Secreted by Normal Breast Epithelium upon Progesterone Stimulation and Increases Proliferation of Stem/Progenitor Cells

Models of breast morphogenesis based on localization of stem cells in the developing mammary lobule

Identification of proteins involved in neural progenitor cell targeting of gliomas

A Novel Model of Dormancy for Bone Metastatic Breast Cancer Cells

Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistance

Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer

Abstract 5907: Fulvestrant resistance in estrogen receptor positive breast cancer models is driven by heterogeneous ER independent transcriptional programs

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium

Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer

Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent

Abstract LB-189: A role of Notch2 in quiescence of mammary stem/progenitor cells

Neural progenitor cell lines inhibit rat tumor growth in vivo

Reduction of the putative CD44+CD24− breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047

Abstract LB-307: Modeling the breast cancer metastatic niche

Abstract LB-190: Growth hormone signaling in mammary stem and progenitor cells

Chemokine-directed migration of tumor-inhibitory neural progenitor cells towards an intracranially growing glioma

Combretastatin A‐1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma

Identification and characterization of a human smad3 splicing variant lacking part of the linker region

Suchergebnisse filtern